Status:
COMPLETED
Improving Work Outcome in People With Recent-onset Schizophrenia
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Schizophrenia
Eligibility:
All Genders
18-45 years
Phase:
PHASE4
Brief Summary
This study will determine the effectiveness of combining antipsychotic medication with Individual Placement and Support (IPS) and group training with the Workplace Fundamentals Module or Brokered Voca...
Detailed Description
The purpose of this protocol is to test, in recent-onset schizophrenia, the efficacy of a rehabilitative intervention that is designed to enhance the search for appropriate work or schooling and to in...
Eligibility Criteria
Inclusion
- First major psychotic episode within 2 years of study entry
- RDC schizophrenia or schizoaffective disorder, mainly schizophrenic subtype
- Residence within commuting distance of UCLA
- Interest in trying to resume work or school
- Speaks English
Exclusion
- Known neurological disorder
- Significant and habitual drug abuse or alcoholism within 6 months of psychotic episode or evidence that substance abuse will be a prominent factor in course of illness
- Mental retardation
- Treatment with risperidone is contraindicated
Key Trial Info
Start Date :
May 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT00203788
Start Date
May 1 1999
End Date
December 1 2006
Last Update
July 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Neuropsychiatric Institute
Los Angeles, California, United States, 90095-6968